Recently published paper by a Japanese group revealed a significantly lower prevalence of MYD88 and CD79B gene mutations in CD5+ DLBCL in contrast to other extranodal DLBCLs [40]. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.